patient selection for neratinib
Published 8 years ago • 801 plays • Length 4:54Download video MP4
Download video MP3
Similar videos
-
4:09
her2 breast cancer: neratinib patient selection
-
1:53
optimal timing for neratinib
-
1:39
dr. anders discusses the use of neratinib/capecitabine for her2-positive brain metastases
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
3:15
neratinib for metastatic breast cancer
-
1:57
dr. dietrich on adverse event management for neratinib in breast cancer
-
5:24
the extenet trial
-
1:09
dr. dang on neratinib in patients with her2 breast cancer
-
3:25
role for neratinib following adjuvant dual-targeted her2 therapy
-
2:18
use of neratinib in her2-positive breast cancer
-
8:47
sramila aithal, md | neratinib and dose escalation | optimizing therapy for her2 disease
-
6:04
dose escalation & managing toxicities of neratinib
-
3:54
practical advice on using neratinib for r/r her2 mbc
-
6:46
yifan tu, md | neratinib and dose escalation | optimizing therapy for her2 disease
-
9:48
francis arena, md | neratinib and dose escalation | optimizing therapy for her2 disease
-
1:30
dr. czerniecki on treatment options for patients with her2 brain metastases
-
8:12
her2 breast cancer: neratinib’s role as adjuvant therapy
-
3:56
sayeh lavasani, md, ms | neratinib and dose escalation | optimizing therapy for her2 disease
-
1:02
dr. freedman on neratinib plus capecitabine for cns disease from her2-positive breast cancer